$PHBI Commenting on Pharmagreen’s progress, Peter Wojcik, President and CEO, stated, “We are very pleased to be working with Oscaleta, its team and its network of brokers/dealers as we move forward with our exciting business model. Furthermore, negotiating a deal that is 85% of the closing bid price is a positive for our company and reflective of NASDAQ listed companies rates.”

PHBI Pharmagreen Signs Term Sheet for $10 Million Equity Purchase Agreement https://finance.yahoo.com/news/pharmagreen-si...00854.html